CR MEDICAL (01515) released its interim financial results, with a net profit attributable to shareholders of 340 million yuan, a decrease of 21.76% year-on-year.

CR MEDICAL (01515) announced the interim performance for the six months ended on June 30, 2025, with a revenue of 4.525 billion yuan (RMB, the same below), a decrease of 9.07% year-on-year; net profit attributable to shareholders was 340 million yuan, a decrease of 21.76% year-on-year; basic earnings per share were 0.27 yuan; proposed to distribute an interim dividend of 5 cents per share. The announcement stated that during the reporting period, the turnover of the hospital business segment was 4.259 billion yuan, a decrease of 7.4% year-on-year. Among them, the number of outpatients and emergencies increased by 1.0%, while the number of inpatients decreased by 3.9%; due to the decrease in average medical insurance expenses, the average revenue for outpatients and emergencies and inpatients decreased by 5.8% each. As of June 30, 2025, the Group operated 103 medical institutions in 10 provinces and cities in China. During the reporting period, the Group's own hospitals had approximately 5.1 million outpatient visits and 270,000 inpatient visits, an increase of 1.0% and a decrease of 3.9% respectively from the same period last year.